Hemorrhagic doses of heparin and other glycosaminoglycans induce a platelet defect

Thrombosis Research - Tập 43 - Trang 491-495 - 1986
F. Fernandez1, P. N'guyen1, J. Van Ryn1, F.A. Ofosu1, J. Hirsh1, M.R. Buchanan1
1McMaster University Medical Centre, Department of Pathology, and Canadian Red Cross Blood Transfusion Centre, Hamilton, Ontario L8N 325 Canada

Tài liệu tham khảo

Carter, 1982, The relationship between the hemorrhagic and antithrombotic properties of low molecular weight heparin in rabbits, Blood, 59, 1239, 10.1182/blood.V59.6.1239.1239 Cade, 1984, A comparison of the antithrombotic and hemorrhagic effects of low molecular weight heparin fractions: The influence of method of preparation, Thromb. Res, 35, 613, 10.1016/0049-3848(84)90265-2 Salzman, 1980, Effect of heparin and heparin fractions on platelet aggregation, J. Clin. Invest, 65, 64, 10.1172/JCI109661 Sie, 1982, Inhibition of thrombin-induced platelet aggregation and serotonin release by antithrombin III and heparin cofactor II in the presence of standard heparin, dematan sulfate and pentosan polysulfate, Thromb. Res, 35, 231, 10.1016/0049-3848(84)90217-2 Hirsh, 1985, Advances in antithrombotic therapy, Vol. 4, 333